GH Research (FRA:1KA) YoY EBITDA Growth : 31.77% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is GH Research YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. GH Research's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 31.77%.

GH Research's EBITDA per Share for the three months ended in Mar. 2024 was €-0.13.

GH Research YoY EBITDA Growth Historical Data

The historical data trend for GH Research's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GH Research YoY EBITDA Growth Chart

GH Research Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

-20.00

-1,450.00

-118.82

-52.58

GH Research Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial													-92.00	-2,316.67	-1,150.00	34.55	31.77

GH Research YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

GH Research's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-0.621	-	-0.407)	/	\| -0.407 \|
=	-52.58 %

GH Research's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(-0.131	-	-0.192)	/	\| -0.192 \|
=	31.77 %

GH Research YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of GH Research's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

GH Research (FRA:1KA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GH Research PLC (FRA:1KA) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

GHRS:USA

Address

28 Baggot Street Lower, Dublin, IRL, D02 NX43

Website

https://www.ghres.com

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. Its focus is on developing novel and proprietary 5-Methoxy-N,N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.

GH Research (FRA:1KA) Headlines

No Headlines